Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
For Startups
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Library

Cube Labs

: 2
: Public company
: 2013

Cube Labs Website, Blog & Press Pages - aVenture Research

Library

cube-labs.comCrawled Nov 13, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

4 pages

FluoDetect/spin-offs/fluodetect
FluoDetect’s fluorescence-based platform detects micro- and nanoplastics in environmental samples, initially targeting water monitoring.
Hiperforming Research/spin-offs/hiperforming-research
Hiperforming Research creates AI-powered tools for research automation, industrial operations, and predictive maintenance using data analytics and IoT.
Lipovexa/spin-offs/lipovexa
Lipovexa develops pharmaceutical and nutraceutical solutions for metabolic diseases, including obesity and diabetes, using small-molecule programs.
Portfolio/portfolio
Cube Labs supports spin-offs developing breakthrough healthcare technologies to improve patient outcomes.

Blog

2 pages

Here’s what the top accelerators in North America are funding/tech/6-steps-to-getting-work-done
Neurodegenerative diseases, saffron and the secret of resilience/general/neurodegenerative-diseases-saffron-and-the-secret-of-resilience
Fortune Health featured Prof. Silvia Bisti’s work at Bio Aurum Srl, which uses saffron-based formulations to target neurodegenerative diseases.

Careers & Hiring

2 pages

Call for Impactful Ventures/call-for-ventures
Join Cube Labs/contacts/join-cube-labs
Cube Labs transforms life sciences research into practical healthcare solutions in a collaborative work environment.

Team

6 pages

Antonio Falcone in Cube-Labs/news/antonio-falcone-in-cube-labs-team
Antonio Falcone joined Cube-Labs as an Equity Partner and Chief Investment Officer, collaborating with Filippo Surace and Renato del Grosso.
Benedetta Palomba/team/benedetta-palomba
Benedetta is a Pharmaceutical Biotechnologist with lab experience in experimental design, data analysis, and research optimization, currently pursuing an MBA.
Fabio Azzarello/team/fabio-azzarello
Fabio is a Junior Product & Project Manager, supporting growth and development of MedTech startups within Cube Labs portfolio.
Loris Spampinato/team/loris-spampinato
Loris is a senior executive with over 30 years of experience in the pharmaceutical and healthcare industries, with deep expertise in business development, international expansion, market access, and strategic alliances.

About

6 pages

About Us/about-us
Cube Labs is an Italian venture builder connecting academic healthcare research with commercial life science markets through new company creation.
Corporate Governance/investors/corporate-governance
DeepCyt/spin-offs/deepcyt
DeepCyt is developing an AI-powered software platform for the analysis of digital images of liquid-based cytology (LBC) microscope slides.
ESG Commitment and Sustainability Report/about-us/esg
The company promotes responsible practices to create a sustainable and equitable healthcare ecosystem.

Homepage

1 page

Homepage/